1. Home
  2. ICFI vs VCEL Comparison

ICFI vs VCEL Comparison

Compare ICFI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$79.67

Market Cap

1.8B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.40

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICFI
VCEL
Founded
1969
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
ICFI
VCEL
Price
$79.67
$37.40
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$99.25
$57.50
AVG Volume (30 Days)
121.6K
398.4K
Earning Date
04-03-2026
05-18-2026
Dividend Yield
0.75%
N/A
EPS Growth
33.79
60.00
EPS
4.01
0.32
Revenue
$1,229,162,000.00
$276,259,000.00
Revenue This Year
N/A
$18.02
Revenue Next Year
$2.52
$18.52
P/E Ratio
$18.74
N/A
Revenue Growth
3.72
16.45
52 Week Low
$72.03
$29.24
52 Week High
$101.71
$52.06

Technical Indicators

Market Signals
Indicator
ICFI
VCEL
Relative Strength Index (RSI) 42.46 53.41
Support Level $74.24 $34.61
Resistance Level $88.80 $38.41
Average True Range (ATR) 3.53 1.70
MACD -0.43 0.24
Stochastic Oscillator 40.15 80.93

Price Performance

Historical Comparison
ICFI
VCEL

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: